The PASCAL system is one of multiple transcatheter repair or replacement therapies under development by Edwards that are designed to address mitral and tricuspid valve diseases. It represents the culmination of 20 years of innovation by Edwards to develop a novel, differentiated and advanced platform for patients in need. The company is building on a long history of knowledge, experience and commitment to advance transformative therapies and develop a robust body of clinical evidence.
The PASCAL system received CE Mark and is available commercially in Europe; it is not approved in the United States.
Ad Statistics
Times Displayed: 50141
Times Visited: 1415 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About Edwards Lifesciences
Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world's leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
SOURCE Edwards Lifesciences Corporation
Back to HCB News
